BOM (3,4,5,beta-tetramethoxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-methoxy derivative of mescaline. BOM was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown.[1] BOM produces few to no effects.[2] Very little data exists about its pharmacological properties, metabolism, and toxicity.

BOM
Names
Preferred IUPAC name
2-Methoxy-2-(3,4,5-trimethoxyphenyl)ethan-1-amine
Other names
3,4,5,beta-Tetramethoxyphenethylamine
2-(3,4,5,beta-Tetramethoxyphenyl)ethanamine
β-methoxymescaline
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C12H19NO4/c1-14-9-5-8(11(7-13)16-3)6-10(15-2)12(9)17-4/h5-6,11H,7,13H2,1-4H3 checkY
    Key: GAKIJEPUVBHWCK-UHFFFAOYSA-N checkY
  • InChI=1/C12H19NO4/c1-14-9-5-8(11(7-13)16-3)6-10(15-2)12(9)17-4/h5-6,11H,7,13H2,1-4H3
    Key: GAKIJEPUVBHWCK-UHFFFAOYAE
  • COc1c(cc(cc1OC)C(CN)OC)OC
Properties
C12H19NO4
Molar mass 241.287 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Legality

edit

United Kingdom

edit

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]

See also

edit

References

edit
  1. ^ BOM Entry in PiHKAL
  2. ^ Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  3. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.